News for 'Janssen Products'

Big Pharma cures for ailing heritage monuments

Big Pharma cures for ailing heritage monuments

Rediff.com29 Oct 2009

The world of big pharma and that of cultural heritage protection do not obviously overlap. But in fact there are logical connections, or so claims Dr Alex Valcke, vice president of one of the world's largest pharmaceutical companies, Janssen Pharmaceutica, a subsidiary of Johnson & Johnson.

China rolls out first one-jab COVID-19 vaccine: Report

China rolls out first one-jab COVID-19 vaccine: Report

Rediff.com28 Feb 2021

China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the United States drug regulator on Sunday.

Confusion over UK nod to vaccinated Indian travellers

Confusion over UK nod to vaccinated Indian travellers

Rediff.com22 Sep 2021

There is confusion over the United Kingdom government's vaccine recognition process for Indian travellers as even though Oxford/AstraZeneca Covishield, the India-manufactured Oxford/AstraZeneca COVID-19 vaccine, is on an updated international travel advisory, India is not yet on a list of 17 approved countries.

Pressure on UK to review Covid vax rules for Indians

Pressure on UK to review Covid vax rules for Indians

Rediff.com21 Sep 2021

The UK government is under increasing pressure on Monday to review its COVID-19 vaccine protocol in place for travellers from India, after its updated rules effective from next month failed to recognise Indian vaccines under an expanded list of countries.

Ranbaxy signs Canadian generic deal

Ranbaxy signs Canadian generic deal

Rediff.com20 Jul 2006

Quad foreign ministers resolve to work towards free, open Indo-Pacific

Quad foreign ministers resolve to work towards free, open Indo-Pacific

Rediff.com11 Feb 2022

The foreign ministers of the Quad grouping of India, the US, Australia and Japan on Friday held extensive talks in Melbourne amid escalating tension between Russia and NATO countries over Ukraine, the Afghan crisis and increasing concerns over China's "coercion" in the Indo-Pacific region.

Covaxin emergency use decision likely in 4-6 weeks: WHO

Covaxin emergency use decision likely in 4-6 weeks: WHO

Rediff.com10 Jul 2021

There is a process to be followed for EUL and pre-qualification of vaccines under which a company has to complete phase 3 trials and submit the whole data to the regulatory department of WHO which is examined by an expert advisory group," Swaminathan said.

Trust Indian industry: WHO on delay in Covaxin nod

Trust Indian industry: WHO on delay in Covaxin nod

Rediff.com29 Oct 2021

A technical advisory group of the UN health agency which met on Tuesday has sought "additional clarifications" from Bharat Biotech for Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine.

US lifts Covid curbs on fully-vaccinated travellers from Nov 8

US lifts Covid curbs on fully-vaccinated travellers from Nov 8

Rediff.com26 Oct 2021

The US will lift all restrictions for fully vaccinated international travellers, including from India, from November 8 but they will have to show proof of a negative coronavirus test before boarding a flight to the country, the White House has announced.

Review: Taken 3 takes logic for granted

Review: Taken 3 takes logic for granted

Rediff.com9 Jan 2015

The worse thing about Taken 3 is that it hints at a sequel, says Paloma Sharma.

'I don't see real estate prices coming down'

'I don't see real estate prices coming down'

Rediff.com27 Jan 2017

Real estate will prosper, small developers won't.